📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
80
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
42%
💰 Capital Raise
55%
• Critical: only 0.4 months cash remaining
📉 Score Deterioration
50%
• Score rose 35 points recently (worsening)
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$218.78M
Shares Outstanding9.20M
Float1.78M
Cash$141.3K
Debt$4.33M
Short InterestN/A
🏛 Institutional Holdings
2 institutional holders · 27.6K shares
#1
UBS Group AG
15.6K shares
#2
MORGAN STANLEY
12.1K shares
📉 Short Interest
Short Interest51.7K
Days to Cover1000.0
% of Float2.9%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for MAMK
📊 MAMK FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 MAMK Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.